From the Division of Plastic and Reconstructive Surgery, Virginia Commonwealth University Health System, Richmond, VA.
Department of Diagnostic Radiology, Virginia Commonwealth University Health System, Richmond, VA.
Ann Plast Surg. 2021 Aug 1;87(2):211-221. doi: 10.1097/SAP.0000000000002731.
Modern breast surgery was first introduced in the United States in 1962 with the use of silicone gel-filled breast implants. Over the past 6 decades, development of breast implants has been challenged by a variety of influencers including aesthetic appeal in shape, texture, and material; challenges in managing outcomes such as contracture, disease, and rupture; and public perception of risks associated with implants. In 1992, silicone breast prostheses were banned by the US Food and Drug Administration with exception for use in breast reconstruction, congenital deformities, or to replace existing implants.The ban led to heightened concerns about implants and possible disease manifestations. Knowledge of the historical evolution of breast prostheses is useful for understanding the associated risks and outcomes unique to each breast implant era. This article aimed to explore characteristics of breast implants by generation, with implications for diagnosis and assistance to modern surgical planning for novice plastic surgeons.
现代乳房外科手术于 1962 年在美国首次引入，采用了硅凝胶填充乳房植入物。在过去的 60 年里，乳房植入物的发展受到了多种因素的挑战，包括形状、质地和材料的审美吸引力；管理挛缩、疾病和破裂等结果的挑战；以及公众对与植入物相关风险的看法。1992 年，美国食品和药物管理局（FDA）禁止使用硅胶乳房假体，仅用于乳房重建、先天性畸形或替换现有植入物。该禁令导致人们对植入物及其可能的疾病表现更加关注。了解乳房假体的历史演变有助于理解每个乳房假体时代特有的相关风险和结果。本文旨在通过代际探讨乳房植入物的特点，为新手整形外科医生的诊断和现代手术规划提供帮助。
